HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.

Abstract
The synthesis of radiolabeled metallothionein was induced in rats in vivo by the injection of CuSO4 and [35S]-cysteine. Treatment of "cold" rat liver cytosol "spiked" with purified [35S] metallothionein with Penicillamine and Trientine showed that even at relatively high concentrations (up to 50 mg/g liver, wet weight), these compounds had no effect on the copper peak or the position of the [35S] label in the cytosol eluate after Sephadex G-75 gel filtration. By contrast, incubation of the "spiked" liver cytosol with Trithiomolybdate, even at relatively low concentrations (0.5 mg/g liver, wet weight), resulted in a transfer of metallothionein copper to high molecular weight protein fractions; the position of the [35S] apoprotein was unaffected. This copper "stripping" effect on metallothionein supports clinical and other evidence that thiomolybdates have a genuine decoppering effect in vivo whereas Penicillamine and Trientine have another mode of action and indicates that thiomolybdates might provide a more rational alternate therapy for Wilson's disease patients.
AuthorsA McQuaid, J Mason
JournalJournal of inorganic biochemistry (J Inorg Biochem) Vol. 41 Issue 2 Pg. 87-92 (Feb 01 1991) ISSN: 0162-0134 [Print] United States
PMID2033396 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Sulfur Radioisotopes
  • trithiomolybdic acid
  • Copper
  • Molybdenum
  • Metallothionein
  • Penicillamine
  • Trientine
Topics
  • Animals
  • Copper (metabolism)
  • Cytosol (drug effects, metabolism)
  • Hepatolenticular Degeneration (drug therapy)
  • Liver (drug effects, metabolism)
  • Male
  • Metallothionein (metabolism)
  • Molybdenum (pharmacology)
  • Penicillamine (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Sulfur Radioisotopes
  • Trientine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: